eprintid: 97350
rev_number: 3
eprint_status: archive
dir: disk0/00/09/73/50
datestamp: 2026-06-19 06:04:47
lastmod: 2026-06-19 06:04:47
status_changed: 2026-06-19 06:04:47
type: article
metadata_visibility: show
creators_name: Amonova N, Amonova N
creators_name: Umurova N, Umurova N
title: METABOLIC SYNDROME IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL FEATURES, METABOLIC DISORDERS AND APPROACHES TO CORRECTION
ispublished: pub
abstract: Metabolic syndrome (MS) combined with type 2 diabetes mellitus (T2DM) is one of the most urgent global health problems. It represents a cluster of metabolic and cardiovascular disorders such as abdominal obesity, hypertension, hyperglycemia, dyslipidemia, and insulin resistance [1–3]. The coexistence of MS and T2DM markedly increases the risk of cardiovascular events, nephropathy, and non-alcoholic fatty liver disease. According to IDF and WHO data, the prevalence of MS among diabetic patients reaches 60–80%, emphasizing the need for comprehensive therapeutic strategies to improve metabolic control and prevent complications.
date: 2025-10-30
official_url: https://universalconference.us/index.php/icmse/article/view/5639
full_text_status: public
publication: INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION
volume: 2
number: 9
pagerange: 78
citation:   Amonova N, Amonova N, Umurova N, Umurova N  (2025) METABOLIC SYNDROME IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL FEATURES, METABOLIC DISORDERS AND APPROACHES TO CORRECTION.  INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION, 2 (9).  p. 78.      
document_url: https://arxiv.universalpublishings.com/id/eprint/97350/1/78.pdf